Bacteremia caused by a highly-resistant Streptococcus pneumoniae serotype 19A circulating in a daycare center

International Journal of Infectious Diseases

Volumn 14, Issue SUPPL. 3, 2010, Pages

  Shouval, Dror S ^a,b   Porat, Nurith ^c,d   Dagan, Ron ^c,d   Keller, Nathan ^b,e   Bilavsky, Efraim ^a,b   Sivan, Yoram ^f   Amir, Jacob ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e SHEBA MEDICAL CENTER   (Israel)

^f MINISTRY OF HEALTH   (Israel)

Author keywords

Bacteremia; Serotype; Serotype 19A; Streptococcus pneumoniae

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM ISOLATE; BLOOD CULTURE; CASE REPORT; CHILD; CLONE; DAY CARE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; LEUKOCYTOSIS; MINIMUM INHIBITORY CONCENTRATION; NASOPHARYNX; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CARRIER STATE; CHILD DAY CARE CENTERS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; ISRAEL; PNEUMOCOCCAL INFECTIONS; RIFAMPIN; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VANCOMYCIN;

EID: 77957361593     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.06.033     Document Type: Article

References (13)

1. Kyaw M.H., Lynfield R., Schaffner W.N., Craig A.S., Hadler J., Reingold A., et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006, 354:1455-1463.
2. Messina A.F., Katz-Gaynor K., Barton T., Ahmad N., Ghaffar F., Rasko D., et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J 2007, 26:461-467.
3. McEllistrem M.C., Adams J.M., Patel K., Mendelsohn A.B., Kaplan S.L., Bradley J.S., et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2005, 40:1738-1744.
4. Huang S.S., Platt R., Rifas-Shiman S.L., Pelton S.I., Goldmann D., Finkelstein J.A. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005, 116:e408-e413.
5. Pelton S.I., Huot H., Finkelstein J.A., Bishop C.J., Hsu K.K., Kellenberg J., et al. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 2007, 26:468-472.
6. Shouval D.S., Greenberg D., Givon-Lavi N., Porat N., Dagan R. The potential coverage of Streptococcus pneumoniae conjugate vaccines in children: differences between invasive disease (ID), acute otitis media (AOM), acute conjunctivitis (AC) and nasopharyngeal carriage in healthy children. Presented at the 23rd Meeting of the European Society for Pediatric Infectious Diseases 2005.
7. Singleton R.J., Hennessy T.W., Bulkow L.R., Hammitt L.L., Zulz T., Hurlburt D.A., et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007, 297:1784-1792.
8. Byington C.L., Korgenski K., Daly J., Ampofo K., Pavia A., Mason E.O. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006, 25:250-254.
9. Shouval D.S., Greenberg D., Givon-Lavi N., Porat N., Dagan R. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 2009, 28:277-282.
10. Hanage W.P., Huang S.S., Lipsitch M., Bishop C.J., Godoy D., Pelton S.I., et al. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis 2007, 195:347-352.
11. Gertz R.E., McEllistrem M.C., Boxrud D.J. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol. 2003, 41:4194-4216.
12. Greenberg D., Dagan R., Muallem M., Porat N. Antibiotic-resistant invasive pediatric Streptococcus pneumoniae clones in Israel. J Clin Microbiol. 2003, 41:5541-5545.
13. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement, M100-S12.